Bio-Techne ordered to pay former CEO $35.98M over option expiration error

BIO-TECHNE Corp

Arbitrator awarded former CEO Charles Kummeth $35.978M for options lost due to administrative error.
Options expired August 9, 2024 per award agreements; company's platform erroneously showed October 26, 2024.
Interest of $980,000 and legal fees/costs of $234,000 also awarded to Kummeth.
Award calculated using average closing price of TECH common stock over 30 days before actual expiration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.